Please use this identifier to cite or link to this item:
Title: PIPAC for peritoneal cancer: The Epworth experience.
Epworth Authors: Lynch, Craig
Zimet, Allan
Keywords: Peritoneal Cancer
Pressurized Intraperitoneal Aerosol Chemotherapy
High Pressure Micro Injection Pump
Localised Therapy
Enhanced Tolerability
Issue Date: Oct-2023
Conference Name: Epworth HealthCare Research Month 2023
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: Peritoneal carcinomatosis has a relentlessly aggressive clinical course. Pressurized Intraperitoneal Aerosol Chemotherapy entails accessing the abdominal cavity using standard laparoscopic techniques and delivering aerosolized chemotherapeutic agents via a high pressure micro injection pump. This novel therapeutic approach can repeatedly deliver a localised therapy with enhanced tolerability and minimal morbidity to improve local disease control. Early results suggest PIPAC is feasible, safe, and well tolerated. Patients having repeated PIPAC procedures had increased survival. Limitations include the small sample size and heterogeneity of the patient group.
Type: Conference Poster
Affiliated Organisations: ANU College of Health & Medicine, The Australian National University, Canberra.
Type of Clinical Study or Trial: N/A
Appears in Collections:Research Month

Files in This Item:
File Description SizeFormat  
Epworth Research month poster Lynch PIPAC.pdf841.59 kBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.